Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Investing Activities: 2013-2024

Historic Cash from Investing Activities for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to -$488.5 million.

  • Surgery Partners' Cash from Investing Activities rose 685.48% to -$46.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$196.9 million, marking a year-over-year increase of 5718.63%. This contributed to the annual value of -$488.5 million for FY2024, which is 11653.37% down from last year.
  • As of FY2024, Surgery Partners' Cash from Investing Activities stood at -$488.5 million, which was down 11653.37% from -$225.6 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Cash from Investing Activities ranged from a high of -$88.4 million in FY2020 and a low of -$488.5 million during FY2024
  • Moreover, its 5-year median value for Cash from Investing Activities was -$307.9 million (2022), whereas its average is -$288.4 million.
  • As far as peak fluctuations go, Surgery Partners' Cash from Investing Activities plummeted by 27522.62% in 2021, and later soared by 2672.95% in 2023.
  • Over the past 5 years, Surgery Partners' Cash from Investing Activities (Annual) stood at -$88.4 million in 2020, then crashed by 275.23% to -$331.7 million in 2021, then increased by 7.18% to -$307.9 million in 2022, then rose by 26.73% to -$225.6 million in 2023, then tumbled by 116.53% to -$488.5 million in 2024.
  • Its last three reported values are -$488.5 million in FY2024, -$225.6 million for FY2023, and -$307.9 million during FY2022.